N | Boolean Trial | SDAI | Boolean Practice | CDAI | DAS28 |
---|---|---|---|---|---|
0 | — | — | — | — | — |
1 | 0.54 (0.33–0.87) | 0.98 (0.54–1.81) | 0.59 (0.36–0.97) | 0.92 (0.51–1.64) | — |
2 | 0.55 (0.33–0.92) | 0.58 (0.32–1.06) | 0.51 (0.31–0.86) | 0.44 (0.24–0.80) | 0.58 (0.28–1.17) |
3 | 0.48 (0.28–0.82) | 0.39 (0.21–0.73) | 0.50 (0.29–0.86) | 0.42 (0.24–0.75) | 0.48 (0.26–0.91) |
4 | 0.29 (0.16–0.51) | 0.56 (0.31–1.01) | 0.40 (0.23–0.70) | 0.50 (0.28–0.90) | 0.46 (0.25–0.85) |
5 | 0.24 (0.13–0.47) | 0.36 (0.20–0.68) | 0.29 (0.16–0.54) | 0.38 (0.21–0.70) | 0.23 (0.12–0.44) |
6 | 0.07 (0.03–0.15) | 0.10 (0.05–0.20) | 0.07 (0.03–0.14) | 0.07 (0.04–0.15) | 0.15 (0.08–0.29) |
J-HAQ: Japanese version of the Health Assessment Questionnaire; N: no. data collections in which patients achieved remission criteria; SDAI: Simplified Disease Activity Index; CDAI: Clinical Disease Activity Index; DAS28: 28-joint Disease Activity Score.